TrialDiabetes, obesity & metabolism2018

Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study.

Samuel Dagogo-Jack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.